Biosimilar monoclonal antibodies in lymphoma: a critical appraisal.
about
Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published EvidenceBiosimilars for the Treatment of Cancer: A Systematic Review of Published EvidenceComparability of Antibody-Mediated Cell Killing Activity Between a Proposed Biosimilar RTXM83 and the Originator Rituximab.Biosimilars in oncology and inflammatory diseases: current and future considerations for clinicians in Latin America
P2860
Biosimilar monoclonal antibodies in lymphoma: a critical appraisal.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Biosimilar monoclonal antibodies in lymphoma: a critical appraisal.
@en
type
label
Biosimilar monoclonal antibodies in lymphoma: a critical appraisal.
@en
prefLabel
Biosimilar monoclonal antibodies in lymphoma: a critical appraisal.
@en
P2860
P1476
Biosimilar monoclonal antibodies in lymphoma: a critical appraisal.
@en
P2093
Catherine Rioufol
Gilles Salles
P2860
P304
P356
10.1586/14737140.2015.1028919
P577
2015-03-30T00:00:00Z